Deutsche Bank analyst Pito Chickering raised the firm’s price target on HCA Healthcare to $310 from $280 and keeps a Buy rating on the shares. The analyst says the company’s Q1 results justify the stock’s "peak multiples."
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on HCA: